Base editing corrected a mutation that causes macular degeneration, highlighting the potential of gene therapy to treat ...

Macular degeneration, particularly age-related macular degeneration, is a leading cause of vision loss worldwide. This ...

A team of scientists at the National Institutes of Health (NIH) has developed an eye drop that successfully slowed vision ...

Red light therapy may help slow down the progression of macular degeneration. But more research is needed into the long-term effects and safety of red light therapy for the eyes. Red light therapy ...

Investigators advised clinicians of the potential for dystrophies that mimic age-related macular degeneration and other ...

Avirmax Biopharma Inc. has begun IND-enabling studies of ABI-201, a gene therapy for dry age-related macular degeneration (AMD). ABI-201 is an AAV vector that delivers three genes to correct the ...

Macular degeneration and cataracts are two different ... injections [MR GZ] Wet AMD can be treated with photodynamic therapy and anti-vascular endothelial growth factor (anti-VEGF) drugs, which ...

March 7, 2025 – The FDA has approved a new gene therapy for macular telangiectasia type 2 (MacTel), a rare eye disease that causes vision loss. The approval marks the first and only ...

a leader in developing the next generation of AAV gene therapies ... dry AMD and many other retinal disorders." Age-related Macular Degeneration is the leading cause of irreversible blindness ...